HEPATITIS C VIRUS (HCV)

Clinical trials for HEPATITIS C VIRUS (HCV) explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS C VIRUS (HCV) trials appear

Sign up with your email to follow new studies for HEPATITIS C VIRUS (HCV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1

New hope for hepatitis c patients who relapsed: 12-week drug combo shows promise

Disease control Ongoing

This study tests a 12-week course of three antiviral drugs (sofosbuvir, velpatasvir, voxilaprevir) in 200 adults with chronic hepatitis C whose infection returned after earlier treatment. The main goal is to see if the virus becomes undetectable 12 weeks after finishing the drugs…

Matched conditions: HEPATITIS C VIRUS (HCV)

Sponsor: Xiangya Hospital of Central South University • Aim: Disease control

Last updated May 11, 2026 20:39 UTC

HEPATITIS C VIRUS (HCV)

Get alerted when new HEPATITIS C VIRUS (HCV) trials appear

New hope for hepatitis c patients who relapsed: 12-week drug combo shows promise